Viewing Study NCT04500470



Ignite Creation Date: 2024-05-06 @ 3:02 PM
Last Modification Date: 2024-10-26 @ 1:41 PM
Study NCT ID: NCT04500470
Status: COMPLETED
Last Update Posted: 2022-01-19
First Post: 2020-08-03

Brief Title: Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography
Sponsor: Aswan University Hospital
Organization: Aswan University Hospital

Study Overview

Official Title: Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide INH Prior to Hysterosalpingography in Primarily Infertile Patients a Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2022-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of our study is to determine the efficacy of Ketoprofen with or without vaginal isonicotinic acid hydrazide on the pain scores during HSG
Detailed Description: hysterosalpingography can cause pain and discomfort in several ways Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion trans-cervical actions including measuring uterine depth inserting the cannula and injection of the dye

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None